Research News

  • Larner Team Plays Role in NIH COVID-19 Blood Clotting Treatment Trials
    The University of Vermont (UVM) is participating in a major national research effort to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed and hospitalized with COVID-19—the disease caused by SARS-CoV-2.
  • Memorial Sloan Kettering’s Brentjens Delivers 5th Annual Stetson Lecture
    Renier Brentjens, M.D., Ph.D., director of cellular therapeutics in the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, presented the 5th Annual Stetson Lecture in Technological Advances in Medicine via Zoom on September 8. He discussed “CARs and Armored CARs: Improving CAR T Cell Therapy for Cancer.”
  • Raszka in Wall Street Journal, CBS6 Albany Stories on COVID-19 and Children
    (AUGUST 10 & 12, 2020) Professor of Pediatrics William Raszka, M.D., was quoted in an August 10 Wall Street Journal article, titled “Latest Research Points to Children Carrying, Transmitting Coronavirus” CBS6 Albany story, titled "Spike in COVID-19 cases in children nationally, a pediatrics professor explains why."
  • Larner Grants Lead in Record-Setting Year for UVM Research Funding
    The University of Vermont received $181.7 million in research funding during the 2020 fiscal year - the largest in UVM history by a wide margin. The Larner College of Medicine had the largest number of grants.
  • Sigmon Listed in Fast Company's "Most Creative People in Business" for 2020
    (AUGUST 4, 2020) Associate Professor of Psychiatry Stacey Sigmon, Ph.D., is featured in the September 2020 issue of Fast Company as one of the 74 “Most Creative People in Business for 2020.” Sigmon is featured under the category of "For Designing A Superior Solution" for her work developing new models of opioid treatment delivery.
  • VT Substance Use Prevention Studies Use Novel Approach to Keep Young People Engaged
    Ensuring the effectiveness of policies and media campaigns targeting young people is critical to achieving substance use prevention, but state surveillance systems are often not nimble enough to capture quickly changing substance use trends. New findings from UVM researchers and colleagues highlight how a uniquely flexible survey instrument and use of incentives help capture relevant data and keep young Vermonters engaged.
  • An & Colleagues Use Computer Modeling to Help Researchers Battle COVID-19
    In late March, Professor of Surgery Gary An, M.D., and Assistant Professor of Surgery R. Chase Cockrell, Ph.D., joined an international coalition of virologists, pharmacologists, and mathematicians to help build a computer model of SARS-CoV-2 tissue that simulates the changing behavior of the virus once it enters the body.
  • Vermont Integrative Genetics Resource Celebrates Milestones, Grant Support
    Despite the many challenges academic institutions have faced in 2020, the Vermont Integrative Genetics Resource (VIGR) shared core facility at the University of Vermont Cancer Center and Larner College of Medicine has achieved strong funding support and achieved some significant milestones over the past six months.
  • Atherly Receives RWJ Grant to Study Vermont Community Health Teams
    A new, three-year $500,000 grant from the Robert Wood Johnson Foundation will allow members of the UVM Center for Health Services Research (CHSR) at the Larner College of Medicine, led by center director and Professor of Medicine Adam Atherly, Ph.D., to explore the effectiveness of community health teams in improving the quality and efficiency of health care delivery.
  • Atherly Extensively Quoted in Healthcare Innovation Article
    (JUNE 11, 2020) Adam Atherly, Ph.D., professor of medicine and director of the Center for Health Services Research, is quoted extensively in a Healthcare Innovation article, titled “Are Vermont’s Global Budgets, Community Health Teams Improving Outcomes?”